David Parry
Private Equity Investor at Samsara Biocapital LLC
David Parry active positions
Companies | Position | Start | End |
---|---|---|---|
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 2021-09-30 | - |
Career history of David Parry
Former positions of David Parry
Companies | Position | Start | End |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | 2019-06-30 | 2021-09-30 |
PORTOLA PHARMACEUTICALS, INC. | Director/Board Member | 2011-11-30 | 2013-02-28 |
MERCK & CO., INC. | Corporate Officer/Principal | 2008-12-31 | 2010-12-31 |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Corporate Officer/Principal | 2004-12-31 | 2008-12-31 |
Training of David Parry
University of Manchester Institute of Science & Technology | Undergraduate Degree |
Imperial Cancer Research Fund Trading Ltd. | Doctorate Degree |
Statistics
International
United States | 5 |
United Kingdom | 4 |
Operational
Corporate Officer/Principal | 3 |
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GSK PLC | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 3 |
---|---|
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
- Stock Market
- Insiders
- David Parry
- Experience